Artigo de periodico

The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population (2023)

• Authors:
  • Farias, Jéssica Pires
  • Andreata-Santos, Robert
  • Brito, Ruth Dalety da Silva
  • Souza, Milena Silva
  • Fogaça, Mayanna Moreira Costa
  • Pinheiro, Josilene Ramos
  • Cruz, Edgar Ferreira da
  • Liang, Willian
  • Simões, Rafael da Conceição
  • Luiz, Wilson Barros
  • Birbrair, Alexander
  • Vidal, Paloma Oliveira
  • Maricato, Juliana Terzi
  • Braconi, Carla Torres
  • Janini, Luiz Mário Ramos
  • Amorim, Jaime Henrique
  • Ferreira, Luis Carlos de Souza
• Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
• Unidade: ICB
• DOI: 10.1128/spectrum.02857-23
• Subjects: MICROBIOLOGIA; COVID-19; EPITOPOS; VARIAÇÃO GENÉTICA; VACINAS VIRAIS; ANTICORPOS; GENOMAS; SEQUENCIAMENTO GENÉTICO; ESTUDOS RETROSPECTIVOS
• Agências de fomento:
  • Financiamento CAPES
  • Financiamento CNPq
  • Financiamento FAPESB
  • Financiamento (FINEP)
  • Financiamento FAPESP
• Language: Inglês
• Imprenta:
  • Publisher: American Society for Microbiology
  • Publisher place: Washington, DC
  • Date published: 2023
• Source:
  • Título: Microbiology Spectrum
  • ISSN: 2165-0497
  • Volume/Número/Paginação/Ano: v. 11, n. 6, art. e02857-23, 16 p., 2023

Informações sobre o DOI: 10.1128/spectrum.02857-23 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo NÃO é de acesso aberto
  

---

Download do texto completo

Tipo	Nome	Link
	The fourth COVID-19 vacci...	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  FARIAS, Jéssica Pires et al. The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, v. 11, n. 6, p. 16 , 2023Tradução . . Disponível em: https://doi.org/10.1128/spectrum.02857-23. Acesso em: 20 jan. 2026.

• APA

  Farias, J. P., Andreata-Santos, R., Brito, R. D. da S., Souza, M. S., Fogaça, M. M. C., Pinheiro, J. R., et al. (2023). The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population. Microbiology Spectrum, 11( 6), 16 . doi:10.1128/spectrum.02857-23

• NLM

  Farias JP, Andreata-Santos R, Brito RD da S, Souza MS, Fogaça MMC, Pinheiro JR, Cruz EF da, Liang W, Simões R da C, Luiz WB, Birbrair A, Vidal PO, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S. The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population [Internet]. Microbiology Spectrum. 2023 ; 11( 6): 16 .[citado 2026 jan. 20 ] Available from: https://doi.org/10.1128/spectrum.02857-23

• Vancouver

  Farias JP, Andreata-Santos R, Brito RD da S, Souza MS, Fogaça MMC, Pinheiro JR, Cruz EF da, Liang W, Simões R da C, Luiz WB, Birbrair A, Vidal PO, Maricato JT, Braconi CT, Janini LMR, Amorim JH, Ferreira LC de S. The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population [Internet]. Microbiology Spectrum. 2023 ; 11( 6): 16 .[citado 2026 jan. 20 ] Available from: https://doi.org/10.1128/spectrum.02857-23

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Bacillus subtilis e vacinas: avanços na pesquisa de veículos vacinais baseados em linhagens geneticamente modificadas de B. subtilis
• Functional and immunological characterization ofa natural polymorphic variantofa heat-labile toxin(LT-I)produced by enterotoxigenicEscherichia coli (ETEC)
• Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant
• Effect of gender on training-induced vascular remodeling in SHR
• Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
• A therapeutic Her2/neu vaccine targeting dendritic cells preferentially inhibits the growth of low Her2/neu–expressing tumor in HLA-A2 transgenic mice
• Biosensor-based selective detection of Zika virus specific antibodies in infected individuals
• Immunomodulatory properties of the enterotoxigenic Escherichia coli type IIa heat-labile enterotoxin (LT-IIa) in mice immunized via the intradermal route
• Study of the natural diversity of heat-labile toxins (LT) produced by enterotoxigenic escherichia coli (ETEC) strains human-derived as an approach for the discovery of new vaccine adjuvants
• Vaccine development using live Salmonella enterica SV typhimurium strains deleted in flagellin -encoding genes using lambda red recombination approach